Quantitative immunofluorescence and mRNA analysis of immune-related biomarker groups in matched paired tumor samples from OPHELIA window study in head and neck squamous cell carcinoma (HNSCC).
Amanda Psyrri(National and Kapodistrian University of Athens), David L. Rimm(Yale University), Thazin Nwe Aung(Yale University), Dimitrios Pectasides(National and Kapodistrian University of Athens), Periklis Foukas(National and Kapodistrian University of Athens), Ioannis Vathiotis(Yale Cancer Center), Georgia-Angeliki Koliou(Hellenic Cooperative Oncology Group), Μaria Anastasiou(National and Kapodistrian University of Athens), George Fountzilas(Hellenic Cooperative Oncology Group), Μαρία Γκοτζαμανίδου(National and Kapodistrian University of Athens), Stavros Gkolfinopoulos(National and Kapodistrian University of Athens), Aileen I. Fernandez(Yale University), Vesal Yaghoobi(Yale University), George Papaxoinis(St Savas Hospital), Ioannis Kotsantis(National and Kapodistrian University of Athens), Myrto Moutafi(University General Hospital Attikon), Panagiota Economopoulou(National and Kapodistrian University of Athens), Saba Shafi(Ministry of Education of the People's Republic of China), Niki Gavrielatou(National and Kapodistrian University of Athens)
Cited by 2
Related Papers
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
|JAMA Oncology|2015|834
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753